Investment
Features
FeesSafety
Academy
More
Pluang+

Compare iShares Global Clean Energy ETF (ICLN) vs Medtronic PLC (MDT) Price & Performance

iShares Global Clean Energy ETFTrade
Medtronic PLCTrade

Price performance (Past 24H)

Key statistics

iShares Global Clean Energy ETF vs Medtronic PLC — how do they compare? iShares Global Clean Energy ETF trades at $18.48, while Medtronic PLC trades at $82.85 (market cap $106.61B). The key difference: Medtronic PLC pays a 3.46% dividend while iShares Global Clean Energy ETF pays none, and iShares Global Clean Energy ETF is trading nearer its 52-week high, Medtronic PLC nearer its low. Which is the better fit depends on your goals.

ICLNMDT
52-Week High
$23.75$105.35
52-Week Low
$13.41$73.75
Market Cap
$106.61B
Sector
Health
Enterprise Value
$125.36B
Dividend Yield
3.46%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

iShares Global Clean Energy ETF

ICLN, the iShares Global Clean Energy ETF, is trading at $18.14, down 1.25% on the day, with a bearish technical outlook. The ETF provides exposure to 105 global renewable energy companies but lacks key valuation metrics like P/E and P/S ratios. Recent news highlights strong 2026 performance with over 25% gains, driven by AI-related power demand and global energy security concerns.

The outlook for ICLN is mixed, balancing strong sector tailwinds against policy risks. Investment opportunities include exposure to the growing clean energy transition, while risks involve US permit delays threatening $121 billion in projects and ongoing comparisons showing higher-yielding alternatives. The technical picture suggests near-term pressure with key support at $18.

Medtronic PLC

Medtronic (MDT) trades at $83.54, up 0.41% today, with a bullish technical signal from moving averages. The company reported strong revenue growth to $33.54B in 2025 and has beaten EPS estimates for three consecutive quarters. Recent acquisitions, including SPR and Scientia Vascular, expand its pain therapy and neurovascular portfolios. Valuation ratios show a P/E of 22.31 and P/S of 2.95, with a consensus price target of $97.50 implying significant upside.

The outlook is positive, supported by robust fundamentals, analyst optimism, and strategic expansions. Key risks include rising debt levels and competitive pressures in medical technology. With no sell ratings from analysts and a dividend yield near a decade high, MDT presents a compelling long-term opportunity for growth and income investors, though macroeconomic and execution risks warrant monitoring.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About iShares Global Clean Energy ETF

The index is designed to track the performance of approximately 100 clean energy-related companies. The fund generally invests at least 80% of its assets in the component securities of the target index. The index may invest up to 20% of its assets in certain futures, trading options and swap contracts, cash and cash equivalents, as well as in securities not included in the index. It is non-diversified.

Read more on ICLN

About Medtronic PLC

One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.

Read more on MDT